D. Serfaty

819 total citations
52 papers, 504 citations indexed

About

D. Serfaty is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Reproductive Medicine. According to data from OpenAlex, D. Serfaty has authored 52 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Public Health, Environmental and Occupational Health, 12 papers in Pediatrics, Perinatology and Child Health and 8 papers in Reproductive Medicine. Recurrent topics in D. Serfaty's work include Reproductive Health and Contraception (28 papers), Pregnancy and Medication Impact (5 papers) and Ovarian function and disorders (5 papers). D. Serfaty is often cited by papers focused on Reproductive Health and Contraception (28 papers), Pregnancy and Medication Impact (5 papers) and Ovarian function and disorders (5 papers). D. Serfaty collaborates with scholars based in France, United States and Israel. D. Serfaty's co-authors include Ronald T. Burkman, Rael D. Strous, J Henry‐Suchet, Sophie Christin‐Maître, D Chassard, Nathalie Chabbert‐Buffet, Y Pérol, C. Debache, F Catalán and Aaron D. Cherniak and has published in prestigious journals such as Journal of Clinical Oncology, Annals of the New York Academy of Sciences and American Journal of Obstetrics and Gynecology.

In The Last Decade

D. Serfaty

44 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Serfaty France 13 280 100 82 71 54 52 504
A. Pinol Switzerland 14 216 0.8× 82 0.8× 99 1.2× 20 0.3× 54 1.0× 23 449
Egbert A. van der Meulen Netherlands 7 123 0.4× 39 0.4× 35 0.4× 37 0.5× 47 0.9× 17 384
Maryam Afrakhteh Iran 13 101 0.4× 51 0.5× 98 1.2× 76 1.1× 33 0.6× 42 434
Gunilla Sundell Sweden 10 462 1.6× 181 1.8× 80 1.0× 78 1.1× 57 1.1× 11 600
Bruce H. Albrecht United States 12 344 1.2× 225 2.3× 160 2.0× 63 0.9× 61 1.1× 22 678
Linda French United States 9 197 0.7× 72 0.7× 27 0.3× 21 0.3× 29 0.5× 21 361
Wendy S. Biggs United States 12 128 0.5× 35 0.3× 44 0.5× 19 0.3× 79 1.5× 28 579
Nilson Roberto de Melo Brazil 18 434 1.6× 271 2.7× 133 1.6× 24 0.3× 68 1.3× 53 891
Mahin Najafian Iran 12 162 0.6× 40 0.4× 125 1.5× 11 0.2× 33 0.6× 59 404
Małgorzata Mizgier Poland 12 134 0.5× 103 1.0× 27 0.3× 13 0.2× 32 0.6× 71 321

Countries citing papers authored by D. Serfaty

Since Specialization
Citations

This map shows the geographic impact of D. Serfaty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Serfaty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Serfaty more than expected).

Fields of papers citing papers by D. Serfaty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Serfaty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Serfaty. The network helps show where D. Serfaty may publish in the future.

Co-authorship network of co-authors of D. Serfaty

This figure shows the co-authorship network connecting the top 25 collaborators of D. Serfaty. A scholar is included among the top collaborators of D. Serfaty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Serfaty. D. Serfaty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vahdat, Heather L., et al.. (2024). The role of advocacy in sustaining male contraceptive research and development. Andrology. 12(7). 1600–1604. 1 indexed citations
3.
Serfaty, D., V N Prilepskaya, Olivier Graesslin, et al.. (2023). Efficacy, safety and acceptability of a benzalkonium chloride spermicide cream in women aged 40 years and over needing contraception: A prospective multicentre study. Journal of Gynecology Obstetrics and Human Reproduction. 52(7). 102616–102616.
4.
Serfaty, D.. (2019). Update on the contraceptive contraindications. Journal of Gynecology Obstetrics and Human Reproduction. 48(5). 297–307. 25 indexed citations
5.
Plu‐Bureau, Geneviève, et al.. (2016). The CORALIE study: improving patient education to help new users better understand their oral contraceptive. The European Journal of Contraception & Reproductive Health Care. 21(5). 388–394. 8 indexed citations
6.
Hamy, Anne‐Sophie, et al.. (2014). Contraception after breast cancer: a retrospective review of the practice among French gynecologists in the 2000's.. PubMed. 35(2). 149–53. 2 indexed citations
7.
Serfaty, D.. (2014). Contraception des femmes allaitantes : place des spermicides. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 44(1). 18–27. 6 indexed citations
8.
Merki‐Feld, Gabriele S., Sven O. Skouby, D. Serfaty, et al.. (2014). European Society of Contraception Statement on Contraception in Obese Women. The European Journal of Contraception & Reproductive Health Care. 20(1). 19–28. 28 indexed citations
10.
Burkman, Ronald T., et al.. (2010). The evolution of combined oral contraception: improving the risk-to-benefit ratio. Contraception. 84(1). 19–34. 52 indexed citations
11.
Marco, Fernando, et al.. (2007). Reconstruction of bone defects with impacted allograft in femoral stem revision surgery. International Orthopaedics. 31(4). 457–464. 13 indexed citations
13.
Creatsas, George, Jacques Drouin, D. Serfaty, et al.. (2001). A multinational evaluation of the efficacy, safety and acceptability of the Protectaid contraceptive sponge.. PubMed. 6(3). 172–82. 13 indexed citations
14.
Serfaty, D.. (1999). Guaranteeing freedom of choice in matters of contraception and abortion in Europe: Some personal remarks. The European Journal of Contraception & Reproductive Health Care. 4(4). 237–245. 2 indexed citations
15.
Serfaty, D., et al.. (1998). A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg gestodene. The European Journal of Contraception & Reproductive Health Care. 3(4). 179–189. 28 indexed citations
16.
Serfaty, D.. (1997). Oral Contraceptive Compliance during Adolescence. Annals of the New York Academy of Sciences. 816(1). 422–431. 13 indexed citations
17.
Serfaty, D., et al.. (1992). Retinoids and Contraception. Dermatology. 184(3). 161–170. 5 indexed citations
18.
Serfaty, D.. (1992). Medical aspects of oral contraceptive discontinuation. Advances in Contraception. 8(S1). 21–33. 25 indexed citations
19.
Mandelbaum, Jacqueline, et al.. (1975). Hypogonadisme hypogonadotrope masculin. Succès du traitement de la stérilité par HMG + HCG. Annales d Endocrinologie. 36(4). 2 indexed citations
20.
Mandelbaum, Jacqueline, et al.. (1975). [Male hypogonadotropic hypogonadism. Success of treatment of sterility with HMG plus HCG].. PubMed. 36(4). 211–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026